Clinical Trial Update: Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine [Phase 1]

View source ↗

Summary

This completed Phase 1 study evaluated the safety and immunogenicity of Genocea Biosciences' prophylactic Streptococcus pneumoniae vaccine. The trial assessed e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease
• Meningitis Pneumococcal
• Pneumococcal Disease
• Pneumonia

Drugs mentioned

• Genocea Streptococcus pneumoniae vaccine

Snippet

Sponsor: Genocea Biosciences, Inc. | Conditions: Streptococcus Pneumoniae | Phase 1 | Status: COMPLETED